Home Cart 0 Sign in  

[ CAS No. 4025-64-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 4025-64-3
Chemical Structure| 4025-64-3
Structure of 4025-64-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4025-64-3 ]

Related Doc. of [ 4025-64-3 ]

Alternatived Products of [ 4025-64-3 ]

Product Details of [ 4025-64-3 ]

CAS No. :4025-64-3 MDL No. :MFCD00024877
Formula : C7H5ClO4S Boiling Point : -
Linear Structure Formula :- InChI Key :LMRKXSDOAFUINK-UHFFFAOYSA-N
M.W : 220.63 Pubchem ID :77641
Synonyms :

Calculated chemistry of [ 4025-64-3 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.48
TPSA : 79.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.06
Log Po/w (XLOGP3) : 1.27
Log Po/w (WLOGP) : 2.39
Log Po/w (MLOGP) : 1.11
Log Po/w (SILICOS-IT) : 0.74
Consensus Log Po/w : 1.31

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.22
Solubility : 1.34 mg/ml ; 0.00606 mol/l
Class : Soluble
Log S (Ali) : -2.55
Solubility : 0.629 mg/ml ; 0.00285 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.32
Solubility : 1.06 mg/ml ; 0.00479 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.82

Safety of [ 4025-64-3 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P280-P303+P361+P353-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4025-64-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4025-64-3 ]
  • Downstream synthetic route of [ 4025-64-3 ]

[ 4025-64-3 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 4025-64-3 ]
  • [ 825-99-0 ]
Reference: [1] Patent: US2453232, 1943, ,
[2] Journal of the Chemical Society, 1921, vol. 119, p. 1796
  • 2
  • [ 110-89-4 ]
  • [ 4025-64-3 ]
  • [ 7311-93-5 ]
YieldReaction ConditionsOperation in experiment
90% at 0℃; for 0.5 h; To a stirred solution of 3-(chlorosulfonyl)benzoic acid (1.10 g, 5.00 mmol) in DCM (10 mL) was added piperidine (1.49 g, 17.5 mmol) at 0° C., and the resulting solution stirred for 30 minutes. The volatiles were then removed in vacuo and the residue treated with aqueous 1N KHSO4. The aqueous phase was then extracted with ethyl acetate (.x.3), and the combined organic phases dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo to afford 3-(piperidin-1-ylsulfonyl)benzoic acid (1.22 g, 4.52 mmol, 90percent).1H NMR (d6 DMSO): 13.54 (1H, br), 8.24 (1H, dt, J 8.0 1.4 Hz), 8.18 (1H, t, J 1.8 Hz), 7.97 (1H, dt, J 8.0 1.6 Hz), 7.79 (1H, t, J 7.7 Hz), 2.93-2.88 (4H, m), 1.58-1.50 (4H, m), 1.40-1.32 (2H, m).
90% at 0℃; for 2 h; To a stirred solution of 3-(chlorosulfonyl) benzoic acid (0.3 g, 1.36 mmol) in DCM (5 mL) was added piperidine (0.35 g, 0.4ml, 4.08 mmol) at 0° C, and the resulting solution was stirred for 2 hours. The volatiles were then evaporated under reduced pressure and the residue treated with aqueous IN KHSO4. The aqueous phase was then extracted with ethyl acetate (x3), and the combined organic phases dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo to give 3-(piperidin-l-ylsulfonyl)benzoic acid as a white solid (0.34 g, 1.262 mmol, 90percent). NMR (400MHZ, CDCL3): 8.41 (1H, br), 8.26 (1H, dt, J= 8.0Hz , 1.4 - - Hz), 7.94 (1H, dt, J= 8.0Hz , 1.6 Hz), 7.61 (1H, t, J= 7.7 Hz), 2.98-2.96 (4H, m), 1.62-1.56 (4H, m), 1.40-1.34 (2H, m). 13C NMR (100 MHz, CDC13): 170.0, 137,6, 133.9, 132.5, 130.3, 129.4, 129.2, 46.9, 25.2, 23.5.
90% at 0℃; for 0.5 h; To a stirred solution of 3-(chlorosulfonyl)benzoic acid (1.10 g, 5.00 mmol) in DCM (10 mL) was added piperidine (1.49 g, 17.5 mmol) at 00C, and the resulting solution stirred for 30 minutes. The volatiles were then removed in vacuo and the residue treated with aqueous IN KHSO4. The aqueous phase was then extracted with ethyl acetate (x3), and the combined organic phases dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo to afford 3-(piperidin-l-ylsulfonyl)benzoic acid (1.22 g, 4.52 mmol, 90percent).1H NMR (d6 DMSO): 13.54 (IH, br), 8.24 (IH, dt, J 8.0 1.4 Hz), 8.18 (IH, t, J 1.8 Hz), 7.97 (IH, dt, J 8.0 1.6 Hz), 7.79 (IH, t, J 1.1 Hz), 2.93-2.88 (4H, m), 1.58-1.50 (4H, m), 1.40-1.32 (2H, m).
Reference: [1] Patent: US2009/192195, 2009, A1, . Location in patent: Page/Page column 13-14
[2] Patent: WO2016/16370, 2016, A1, . Location in patent: Page/Page column 38; 39
[3] Patent: WO2009/93029, 2009, A1, . Location in patent: Page/Page column 39
[4] Journal of Medicinal Chemistry, 2013, vol. 56, # 15, p. 6146 - 6155
[5] ChemMedChem, 2018, vol. 13, # 12, p. 1165 - 1171
  • 3
  • [ 4025-64-3 ]
  • [ 5345-27-7 ]
Reference: [1] Journal of the Chemical Society, 1946, p. 763,766
[2] Patent: US2453232, 1943, ,
[3] Journal of the Chemical Society, 1921, vol. 119, p. 1796
  • 4
  • [ 4025-64-3 ]
  • [ 74-88-4 ]
  • [ 5345-27-7 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1968, vol. 33, p. 3988 - 3999
  • 5
  • [ 4025-64-3 ]
  • [ 636-76-0 ]
YieldReaction ConditionsOperation in experiment
96%
Stage #1: With ammonia In water at 0 - 20℃; for 15 h;
Stage #2: With hydrogenchloride In water
To ice-cold solution of ammonium hydroxide (25percent, 250ml) is added 3-(chlorosulfonyl) benzoic acid (25g, commercially available, Aldrich) portionwise and the mixture is stirred at room temperature for 15h. The solvent is removed under vacuum to about 50ml and the mixture is acidified with cone. HCl. The precipitate is collected by filtration and dried under vacuum to afford 22g (96percent) of the title compound as a white solid. IH NMR (DMSO-d6) δ 13.44 (br s, IH), 8.38 (s, IH), 8.14 (d, J = 7.5 Hz, IH), 8.04 (d, J = 7.9 Hz, IH), 7.72 (t, J = 7.9 Hz, IH), 7.49 (s, 2H), HPLC (max plot) 97percent; Rt 0.68 min. LC/MS: (ES-): 199.8.
95% at 0 - 20℃; for 2 h; To 75 mL of 0 °C cold ammonia (25percent in water) (1002 mmol 30.0 eq) 7.4 g of 3-(chlorosulfonyl)benzic acid, S4,(33.54 mmol, 1.0 eq) was added portion wise. The mixture was stirred for 2 hours at room temperature. The solvent was removed under reduced pressure. The residue was suspended in 25 mL of water and 40 mL of conc. hydrochloric acid were added. The precipitate was collected by vacuum filtration and was washed with water.The crude product was suspended in water and lyophilized to give 6.42 g (95percent) white solid.
64.6% With ammonia In ethyl acetate at 0℃; for 0.5 h; General procedure: To a saturated solution of 3-chloro sulfonyl benzoic acid (8 mmol) in ethyl acetate (4 mL) was added cold concentrated ammonia or methylamine aqueous solution. After stirring for 30 min at 0 deg C., the mixture was neutralized with a solution of HCl in dioxane (4M) and extracted with ethyl acetate. The organic phase was concentrated under reduced pressure to give a solid which was recrystallized from acetonitrile to give desired compound.   3-Sulfamoyl-benzoic Acid[0234][0235]White solid, yield 64.6percent, 1HNMR (300 MHz, DMSO-d6) δ 8.38 (s, 1H, Ar—H), 8.12 (d, J=8.1 Hz, 1H, Ar—H), 8.03 (d, J=7.8 Hz, 1H, Ar—H), 7.71 (t, J=7.5 Hz, J=7.8 Hz, 1H, Ar—H), 7.5 (s, 2H, SO2NH2)
Reference: [1] Patent: WO2007/23186, 2007, A1, . Location in patent: Page/Page column 45
[2] European Journal of Medicinal Chemistry, 2014, vol. 89, p. 503 - 523
[3] Journal of the American Chemical Society, 2011, vol. 133, # 40, p. 16235 - 16242
[4] ChemMedChem, 2015, vol. 10, # 9, p. 1548 - 1558
[5] Patent: US2013/35364, 2013, A1, . Location in patent: Paragraph 0233-0235
[6] Journal of Medicinal Chemistry, 2013, vol. 56, # 15, p. 6146 - 6155
[7] Fermentforschung, 1931, vol. 12, p. 180,208
[8] Journal of the Chemical Society, 1921, vol. 119, p. 1796
[9] Bulletin de la Societe Chimique de France, 1945, vol. <5>12, p. 954,960
[10] Patent: WO2005/44817, 2005, A1, . Location in patent: Page/Page column 96
[11] Archiv der Pharmazie, 2015, vol. 348, # 6, p. 399 - 407
  • 6
  • [ 65-85-0 ]
  • [ 4025-64-3 ]
YieldReaction ConditionsOperation in experiment
88.7% at 100℃; for 0.75 h; 1.22 g (10 mmol) of benzoic acid were weighed into a 50 mL pear-shaped flask and then slowly added10 mL of chlorosulfonic acid was added and stirred at 100 & lt; 0 & gt; C for 45 min. After completion of the reaction, the reaction solution was added dropwise to ice brine,Then vacuum filtration, washing, vacuum drying, in a white solid, yield 88.7percent.
87% at 65℃; for 4 h; Chlorosulfonation of benzoic acid derivatives. A mixture of 1 (5 g, 40.94 mmol) or 2 (5 g, 32.86mmol) in chlorosulfonic acid (20 mL) was heated to 65 °C in an oil bath for 4 h, after which time TLC indicated complete conversion of the starting material to the intermediates, 3-(chlorosulfonyl)benzoic acid (3) and 3-(chlorosulfonyl)-4- methoxybenzoic acid (4), respectively. The reaction mixture was slowly poured over ice and filtered. The solid was dried in vacuo to yield intermediates 3 (7.90 g, 87percent) and 4 (6.40 g, 86percent), which were carried forward without further purification.
85% at 120 - 125℃; for 2 h; Neat (no solvent) Benzoic acid (250 g, 2.05 mol) was placed in a 1-L round-bottom flask, and chlorosulfonic acid (1 L, 1760 g, 15.1 mol) was added. The mixture was heated with stirring at 120-125° C. for 2 h, allowed to cool to 40-50° C., and added dropwise to an excess of crushed ice. The precipitated product was collected by filtration and dissolved in 1 L of ethyl acetate; then the aqueous layer that formed was separated, and the organic layer was washed with 100 mL of water, dried over sodium sulfate, and concentrated by evaporation to near dryness. After trituration with 300 mL of hexane, the product was collected by filtration, washed on the filter with 200 mL of hexane, and dried in air to give 384.1 g (85percent) of 3-chlorosulfonylbenzoic acid, mp 134-135° C. (lit. mp 134-135° C.); 1H NMR (400 MHz, in CDCl3w/TMS, ppm) 11.43 (broad s, CO2H, 7.81 (t, J=8.0 Hz, H-5), 8.32 and 8.50 (2d, J=8.0 Hz, H4 and H-6), 8.79 (t, J=1.6 Hz, H-2); {1H}13C NMR (100 MHz, in CDCl3w/TMS, ppm) 170.00 (CO), 145.06 (C-3), 136.71 (C-6), 131.92 (C-4), 131.31 (C-1), 130.63 (C-5), 128.91 (C-2).
82% at 120 - 125℃; for 2 h; 20 mL of Chlorosulfonic acid (300.4 mmol, 7.34 eq) was added to 5.0 g of benzoic acid, S3, (40.9 mmol 1.0 eq) and the mixture was stirred at 120 - 125 °C. After 2 hours the mixture was added dropwise to 200 mL of ice. The resulting precipitate was collected, dissolved in 150 mL of ethyl acetate, washed with water (3 x 25 mL), driedover Na2SO4, filtered and the solvent was removed under reduced pressure. The crude product was pestled and washed with hexane to give 7.42 g (82percent) of a white solid.
82% at 120℃; for 2 h; Chlorosulfonic acid (2 mL, 300.4 mmol,) was added to125, (500 mg, 40.9 mmol) and the mixture was stirred at 120 °C for 2 h.. After this time the mixture was added dropwise to a mxture of EtOAc (200 mL) and crushed ice. The resulting precipitate was collected, dissolved in ethyl acetate, washed with water (3 x 25 mL) and Brine, dried over Na2SO4, and the solvent was removed under reduced pressure. 1H-NMR (400 MHz, DMSO-d6): (5 = 8.80 (t, J = 1.4 Hz, 1H), 8.40 (m 1H), 8.19 (m, 1H), 7.69 (t, J = 7.5 Hz, 1H).ppm.
80% at 20 - 130℃; for 2.5 h; Solid benzoic acid [(50] g, 0.41 mol) in portions was added to [CHLOROSULFONIC] acid (348.7 g, 200 mL, 3 mol) at room temperature. The reaction mixture was heated to [125-130 C] for 2 hr and was then poured into vigorously stirred crushed-ice (1000 g). After 30 min, the white solid was collected, washed with water [(1] L) and air dried to give 72.5 g (80percent) of the title compound. 1H NMR [(CDCL3] : d4-MeOH 4: 1,60 MHz) 8 5.0 (s, 1H), 8.0-9. 1 (m, 4H).
60% at 5 - 110℃; for 2 h; Benzoic acid (5 g, 40.9 mmol) was added in portions to chlorosulfonic acid (14.3 g, 122.9 mmol) under stirring at 5–10 C and then stirred at 110 C for 2 h. The reaction mixture was cooled to room temperature, poured on to crushed ice (∼100 g) under stirring during which solids precipitated. These solids were filtered, extracted with ethyl acetate (150 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure to obtain the title compound as solid mass (5.4 g, 60percent yield).
54% at 120℃; for 4 h; The benzoic acid 1 (12.20g, 10mmol) was added to chlorosulfonic acid (20mL, 30mmol) with stirring. The mixture was heated at 120°C for 4h. After cooling to rt, the mixture was poured into ice-water (100mL), the formed precipitate was collected by filtration and washed with ice-water. The separated solid was dissolved with ethyl acetate (50mL×3). The combined organic extracts were washed with saturated brine (50mL×2) and dried over anhydrous sodium sulfate overnight. After removal of the solvent, the residue was loaded onto a silica gel column and eluted with PE/EA (1:1, v/v) to afford compound 2 (11.93g) in 54percent yield as white solid. H NMR (400MHz, DMSO-d6) δ 12.27 (s, 1H), 8.20 (s, 1H), 7.89 (d, J=7.7Hz, 1H), 7.83 (d, J=7.7Hz, 1H), 7.47 (t, J=7.7Hz, 1H). 13C NMR (101MHz, DMSO-d6) δ 166.92, 148.50, 130.27, 129.73, 129.31, 128.14, 126.45.
851 g at 90℃; for 11 h; 500g of benzoic acid, 763 g of chlorosulfonic acid was placed in a reactor with a micro-negative pressure alkali absorbing device.Turn on the stirring and add 7.5 g of fuming sulfuric acid.The closed reactor begins to heat up,The temperature was started at 90 ° C, and the GC gas spectrometer was followed. After 11 h, the amount of benzoic acid was ≤ 0.05percent, and the reaction was completed.Reduce the system temperature to 8 ° C,Start adding water while stirring.At first the temperature rose slightly,After the 45g water drop is added,The temperature does not change anymore,Then you can add 45g of water at a time.Stir for a while, let stand, layer,Approximately 862 g of the sulfonated liquid in the lower layer was transferred to another reactor.And adding 86g of anhydrous sodium sulfate and stirring for 1h,After filtration, 851 g of the obtained sulfonated solution was used.The upper aqueous layer is neutralized with alkali and poured into a wastewater tank.

Reference: [1] Patent: CN105732444, 2016, A, . Location in patent: Paragraph 0031; 0032; 0036; 0037; 0038
[2] Patent: WO2014/100833, 2014, A1, . Location in patent: Paragraph 0076
[3] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 961 - 965
[4] Patent: US2005/49307, 2005, A1, . Location in patent: Page/Page column 5
[5] European Journal of Medicinal Chemistry, 2014, vol. 89, p. 503 - 523
[6] Patent: WO2017/162834, 2017, A1, . Location in patent: Page/Page column 96; 97
[7] Patent: WO2004/9583, 2004, A2, . Location in patent: Page 200-201
[8] New Journal of Chemistry, 2017, vol. 41, # 22, p. 13516 - 13532
[9] Journal of Chemical Sciences, 2015, vol. 127, # 3, p. 439 - 445
[10] European Journal of Medicinal Chemistry, 2018, vol. 148, p. 359 - 371
[11] Journal of the Chemical Society, 1921, vol. 119, p. 1796
[12] Tetrahedron, 2004, vol. 60, # 17, p. 3755 - 3762
[13] Journal of the American Chemical Society, 2013, vol. 135, # 15, p. 5656 - 5668
[14] Patent: WO2016/128541, 2016, A1, . Location in patent: Page/Page column 105
[15] Angewandte Chemie - International Edition, 2017, vol. 56, # 1, p. 248 - 253[16] Angew. Chem., 2017, vol. 129, # 1, p. 254 - 259,6
[17] Letters in Drug Design and Discovery, 2016, vol. 13, # 10, p. 1 - 13
[18] Letters in Drug Design and Discovery, 2017, vol. 14, # 11, p. 1239 - 1251
[19] ChemMedChem, 2018, vol. 13, # 12, p. 1165 - 1171
[20] Patent: CN108395389, 2018, A, . Location in patent: Paragraph 0032; 0034; 0035
  • 7
  • [ 7790-94-5 ]
  • [ 65-85-0 ]
  • [ 4025-64-3 ]
YieldReaction ConditionsOperation in experiment
87% at 65℃; for 4 h; General procedure: A mixture of 1 (5g, 40.94mmol) or 2 (5g, 32.86mmol) in chlorosulfonic acid (20mL) was heated to 65°C in an oil bath for 4h, after which time TLC indicated complete conversion of the starting material to the intermediates, 3-(chlorosulfonyl)benzoic acid (3) and 3-(chlorosulfonyl)-4-methoxybenzoic acid (4), respectively. The reaction mixture was slowly poured over ice and filtered. The solid was dried in vacuo to yield intermediates 3 (7.90g, 87percent) and 4 (6.40g, 86percent), which were carried forward without further purification.
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 76, p. 414 - 426
[2] Archiv der Pharmazie, 2015, vol. 348, # 6, p. 399 - 407
  • 8
  • [ 98-88-4 ]
  • [ 4025-64-3 ]
Reference: [1] Patent: US2273974, 1939, ,
  • 9
  • [ 121-53-9 ]
  • [ 4025-64-3 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1858, vol. 106, p. 30
[2] Monatshefte fuer Chemie, 1902, vol. 23, p. 1126,1128
  • 10
  • [ 25116-40-9 ]
  • [ 4025-64-3 ]
Reference: [1] Chemische Berichte, 1957, vol. 90, p. 841,843
  • 11
  • [ 7790-94-5 ]
  • [ 98-88-4 ]
  • [ 4025-64-3 ]
Reference: [1] Patent: US2273974, 1939, ,
[2] Praeparative Organische Chemie, Tl. I (= Naturf. Med. Dtschld. 1939-1946, Bd. 36) <Wiesbaden 1948> S. 254,
[3] Patent: US2273974, 1939, ,
  • 12
  • [ 7446-11-9 ]
  • [ 98-88-4 ]
  • [ 4025-64-3 ]
Reference: [1] Patent: US2273974, 1939, ,
[2] Praeparative Organische Chemie, Tl. I (= Naturf. Med. Dtschld. 1939-1946, Bd. 36) <Wiesbaden 1948> S. 254,
[3] Patent: US2273974, 1939, ,
  • 13
  • [ 4025-64-3 ]
  • [ 124-40-3 ]
  • [ 7326-73-0 ]
YieldReaction ConditionsOperation in experiment
65%
Stage #1: for 0.5 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; dichloromethane; water
A solution of 3-(chlorosulfonyl) benzoic acid (2.60 g, 12 mmol) in DCM (20 ml) was treated with dimethylamine (2.0 M in TΗF, 20 ml, 40 mmol, 3.3 equiv). After 30 min, the reaction was quenched with 10percent HCl and extracted with EtOAc. The organics were washed with NaCl(sat) and then dried with Na2SO4(s). The organics were then removed under reduced pressure to give 1.80 g, 65percent; m/z 229.
65%
Stage #1: for 0.5 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; dichloromethane; water
A solution of 3-(chlorosulfonyl)benzoic acid (2.60 g, 12 mmol) in DCM (20 ml) was treated with dimethylamine (2.0 M in THF, 20 ml, 40 mmol, 3.3 equiv). After 30 min, the reaction was quenched with 10percent HC1 and extracted with EtOAc. The organics were washed with NaCl(Sat) and then dried with Na2S04(S). The organics were then removed under reduced pressure to give 1.80 g, 65percent; m/z 229.
65% for 0.5 h; Method 25; 3-[(Dimethylamino)sulfonyr|benzoic acid; A solution of 3-(chlorosulfonyl) benzoic acid (2.60 g, 12 mmol) in DCM (20 ml) was treated with dimethylamine (2.0 M in THF, 20 ml, 40 mmol, 3.3 equiv). After 30 min, the reaction was quenched with 10percent HCl and extracted with EtOAc. The organics were washed with νaCl(sat) and dried with Na2SO4(S). The organics were then removed under reduced pressure to give 1.80 g, 65percent; m/z 229.
65% at 20℃; for 0.333333 h; Method 128; 5 3 - \\( Dimethylamino)sulfonyll benzoic acid; A solution of 3-(chlorosulfonyl) benzoic acid (2.60 g, 12 mmol) in DCM (20 ml) was treated with dimethylamine (2.0 M in THF, 20 ml, 40 mmol, 3.3 equiv). After 30 min, the reaction was quenched with 10percent HCl and extracted with EtOAc. The organics were washed with NaCl (sat) and then dried with Na2SO4 (s). The organics were then removed under 10 reduced pressure to give 1.80 g, 65percent; m/z 229.

Reference: [1] ChemMedChem, 2015, vol. 10, # 9, p. 1548 - 1558
[2] Patent: WO2006/24834, 2006, A1, . Location in patent: Page/Page column 82
[3] Patent: WO2006/24836, 2006, A1, . Location in patent: Page/Page column 30
[4] Patent: WO2007/71963, 2007, A2, . Location in patent: Page/Page column 50
[5] Patent: WO2006/40568, 2006, A1, . Location in patent: Page/Page column 82
[6] Journal of Medicinal Chemistry, 2013, vol. 56, # 15, p. 6146 - 6155
[7] Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 1807 - 1816
[8] Tetrahedron, 2004, vol. 60, # 17, p. 3755 - 3762
[9] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 18, p. 4552 - 4557
  • 14
  • [ 4025-64-3 ]
  • [ 56542-67-7 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1945, vol. <5>12, p. 954,960
  • 15
  • [ 4025-64-3 ]
  • [ 3118-68-1 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1945, vol. <5>12, p. 954,960
  • 16
  • [ 67-56-1 ]
  • [ 4025-64-3 ]
  • [ 63555-50-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 1, p. 212 - 221
[2] Journal of Medicinal Chemistry, 2007, vol. 50, # 3, p. 442 - 454
  • 17
  • [ 4025-64-3 ]
  • [ 63555-50-0 ]
Reference: [1] Patent: US6177466, 2001, B1,
[2] Patent: CN107540636, 2018, A,
  • 18
  • [ 186581-53-3 ]
  • [ 4025-64-3 ]
  • [ 63555-50-0 ]
Reference: [1] Magnetic Resonance in Chemistry, 1989, vol. 27, # 6, p. 585 - 591
  • 19
  • [ 4025-64-3 ]
  • [ 1423715-09-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 23, p. 9496 - 9508
[2] Patent: WO2013/25805, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4025-64-3 ]

Aryls

Chemical Structure| 10130-89-9

[ 10130-89-9 ]

4-(Chlorosulfonyl)benzoic acid

Similarity: 0.99

Chemical Structure| 89001-57-0

[ 89001-57-0 ]

5-(Chlorosulfonyl)-2-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 63914-81-8

[ 63914-81-8 ]

2-(Chlorosulfonyl)benzoic acid

Similarity: 0.94

Chemical Structure| 2548-29-0

[ 2548-29-0 ]

3-Chlorosulfonyl-4-methylbenzoic acid

Similarity: 0.93

Chemical Structure| 63555-50-0

[ 63555-50-0 ]

Methyl 3-(chlorosulfonyl)benzoate

Similarity: 0.93

Sulfonyl Chlorides

Chemical Structure| 10130-89-9

[ 10130-89-9 ]

4-(Chlorosulfonyl)benzoic acid

Similarity: 0.99

Chemical Structure| 89001-57-0

[ 89001-57-0 ]

5-(Chlorosulfonyl)-2-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 63914-81-8

[ 63914-81-8 ]

2-(Chlorosulfonyl)benzoic acid

Similarity: 0.94

Chemical Structure| 2548-29-0

[ 2548-29-0 ]

3-Chlorosulfonyl-4-methylbenzoic acid

Similarity: 0.93

Chemical Structure| 63555-50-0

[ 63555-50-0 ]

Methyl 3-(chlorosulfonyl)benzoate

Similarity: 0.93

Chlorides

Chemical Structure| 10130-89-9

[ 10130-89-9 ]

4-(Chlorosulfonyl)benzoic acid

Similarity: 0.99

Chemical Structure| 89001-57-0

[ 89001-57-0 ]

5-(Chlorosulfonyl)-2-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 63914-81-8

[ 63914-81-8 ]

2-(Chlorosulfonyl)benzoic acid

Similarity: 0.94

Chemical Structure| 2548-29-0

[ 2548-29-0 ]

3-Chlorosulfonyl-4-methylbenzoic acid

Similarity: 0.93

Chemical Structure| 63555-50-0

[ 63555-50-0 ]

Methyl 3-(chlorosulfonyl)benzoate

Similarity: 0.93

Carboxylic Acids

Chemical Structure| 10130-89-9

[ 10130-89-9 ]

4-(Chlorosulfonyl)benzoic acid

Similarity: 0.99

Chemical Structure| 89001-57-0

[ 89001-57-0 ]

5-(Chlorosulfonyl)-2-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 63914-81-8

[ 63914-81-8 ]

2-(Chlorosulfonyl)benzoic acid

Similarity: 0.94

Chemical Structure| 2548-29-0

[ 2548-29-0 ]

3-Chlorosulfonyl-4-methylbenzoic acid

Similarity: 0.93

Chemical Structure| 37098-75-2

[ 37098-75-2 ]

5-(Chlorosulfonyl)-2-fluorobenzoic acid

Similarity: 0.87